It takes an average of 22 months for a new drug to be listed on the Pharmaceutical Benefits Scheme after it's been deemed safe and effective, according to a recent review.

In preparation for a planned commercial rollout, Telix has contracted with Cardinal health to enable Zircaix®2 availability across a wide range of U.S. locations.

So three hours I've driven here and when we're finished I'll turn around ... her is approved by the Therapeutic Goods Administration, it would take an average of almost two years for it to be ...

Pharmaceuticals are notably the most counterfeited consumer goods, generating substantial ... also poses a persistent industry challenge. An illustrative scenario is as follows: a patient fills ...

Your one-stop shop for all the latest corporate results of South Africa’s major companies. South African lender FirstRand ...

How can the food and drink sector work to mitigate and tackle the damaging impacts of food fraud? Food Manufacture hears from ...

In the case of In re Imtiyaz Kaiyum Barvatiya before the Gujarat Authority for Advance Ruling (AAR), the central issue was ...

Sales of petroleum and coal products led the monthly increase. After rising by 0.4 percent in June, sales in this subsector ...

The major U.S. index futures are currently pointing to a modestly higher open on Wednesday, with stocks likely to move to the upside ...

Growth is fueled by the rising number of temperature-sensitive pharmaceuticals, including biologics, vaccines, and specialty ...

It has a global presence in addition to its strong presence in the Indian market. The Indian Pharmaceutical industry is ranked third in pharmaceutical production by volume, having grown at a CAGR ...

Shares of Zentalis Pharmaceuticals are up 35% in pre-market trade on Monday. For More Such Health News, visit rttnews.com. Zentalis Pharmaceuticals NewsMORE Related Stocks Indices Commodities ...